Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBMX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TANK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXJ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF12-TNFSF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BRD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CSTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFAIP8L2-SCNM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAMP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930531 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on